Figure 5From: Development of a novel small antibody that retains specificity for tumor targetingHistopathological staining revealed numerous fibrous foci (black arrow) in the tumors from the treated group with PMN (b), which were not seen in the other control groups (a). PMN, protomimecin. Scale bar, 50 μm.Back to article page